AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
Selective blockade of vasopressin V-2 receptors reveals significant V-2-mediated water reabsorption in Brattleboro rats with diabetes insipidus
Authors: Pouzet, B Serradeil-Le Gal, C Bouby, N Maffrand, JP Le Fur, G Bankir, L
Citation: B. Pouzet et al., Selective blockade of vasopressin V-2 receptors reveals significant V-2-mediated water reabsorption in Brattleboro rats with diabetes insipidus, NEPH DIAL T, 16(4), 2001, pp. 725-734
Effects of the selective activation of 5-HT3 receptors on sleep: a polysomnographic study in healthy volunteers
Authors: Staner, L Linker, T Toussaint, M Danjou, P Roegel, JC Luthringer, R Le Fur, G Macher, JP
Citation: L. Staner et al., Effects of the selective activation of 5-HT3 receptors on sleep: a polysomnographic study in healthy volunteers, EUR NEUROPS, 11(4), 2001, pp. 301-305
Selective blockade of neurokinin-2 receptors produces antidepressant-like effects associated with reduced corticotropin-releasing factor function
Authors: Steinberg, R Alonso, R Griebel, G Bert, L Jung, M Oury-Donat, F Poncelet, M Gueudet, C Desvignes, C Le Fur, G Soubrie, P
Citation: R. Steinberg et al., Selective blockade of neurokinin-2 receptors produces antidepressant-like effects associated with reduced corticotropin-releasing factor function, J PHARM EXP, 299(2), 2001, pp. 449-458
Reduction of opioid dependence by the CB1 antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction
Authors: Mas-Nieto, M Pommier, B Tzavara, ET Caneparo, A Da Nascimento, S Le Fur, G Rogues, BP Noble, F
Citation: M. Mas-nieto et al., Reduction of opioid dependence by the CB1 antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction, BR J PHARM, 132(8), 2001, pp. 1809-1816
Effect of SR121463, a selective non-peptide vasopressin V-2 receptor antagonist, in a rabbit model of ocular hypertension
Authors: Lacheretz, F Barbier, A Serradeil-Le Gal, C Elena, PP Maffrand, JP Le Fur, G
Citation: F. Lacheretz et al., Effect of SR121463, a selective non-peptide vasopressin V-2 receptor antagonist, in a rabbit model of ocular hypertension, J OCUL PH T, 16(3), 2000, pp. 203-216
Functional assessment of beta adrenoceptor subtypes in human colonic circular and longitudinal (taenia coli) smooth muscle
Authors: Manara, L Croci, T Aureggi, G Guagnini, F Maffrand, JP Le Fur, G Mukenge, S Ferla, G
Citation: L. Manara et al., Functional assessment of beta adrenoceptor subtypes in human colonic circular and longitudinal (taenia coli) smooth muscle, GUT, 47(3), 2000, pp. 337-342
Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes
Authors: Serradeil-Le Gal, C Lafontan, M Raufaste, D Marchand, J Pouzet, B Casellas, P Pascal, M Maffrand, JP Le Fur, G
Citation: C. Serradeil-le Gal et al., Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes, FEBS LETTER, 475(2), 2000, pp. 150-156
The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK1 receptor (vol 400, pg 185, 2000)
Authors: Gouldson, P Legoux, P Carillon, C Delpech, B Le Fur, G Ferrara, P Shire, D
Citation: P. Gouldson et al., The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK1 receptor (vol 400, pg 185, 2000), EUR J PHARM, 407(3), 2000, pp. 333-333
Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB2 receptor
Authors: Gouldson, P Calandra, B Legoux, P Kerneis, A Rinaldi-Carmona, M Barth, F Le Fur, G Ferrara, P Shire, D
Citation: P. Gouldson et al., Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB2 receptor, EUR J PHARM, 401(1), 2000, pp. 17-25
The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK1 receptor
Authors: Gouldson, P Legoux, P Carillon, C Delpech, B Le Fur, G Ferrara, P Shire, D
Citation: P. Gouldson et al., The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK1 receptor, EUR J PHARM, 400(2-3), 2000, pp. 185-194
Essential role of extracellular charged residues of the human CCK1 receptor for interactions with SR 146131, SR 27897 and CCK-8S
Authors: Gouldson, P Legoux, P Carillon, C Dumont, X Le Fur, G Ferrara, P Shire, D
Citation: P. Gouldson et al., Essential role of extracellular charged residues of the human CCK1 receptor for interactions with SR 146131, SR 27897 and CCK-8S, EUR J PHARM, 389(2-3), 2000, pp. 115-124
Blockade of cannabinoid (CB1) receptors by SR 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils
Authors: Poncelet, M Barnouin, MC Breliere, JC Le Fur, G Soubrie, P
Citation: M. Poncelet et al., Blockade of cannabinoid (CB1) receptors by SR 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils, PSYCHOPHAR, 144(2), 1999, pp. 144-150
Blockade of neurotensin receptors suppresses the dopamine D1/D2 synergism on immediate early gene expression in the rat brain
Authors: Alonso, R Gnanadicom, H Frechin, N Fournier, M Le Fur, G Soubrie, P
Citation: R. Alonso et al., Blockade of neurotensin receptors suppresses the dopamine D1/D2 synergism on immediate early gene expression in the rat brain, EUR J NEURO, 11(3), 1999, pp. 967-974
Blockade of neurokinin(3) receptors antagonizes drug-induced population response and depolarization block of midbrain dopamine neurons in guinea pigs
Authors: Gueudet, C Santucci, V Soubrie, P Le Fur, G
Citation: C. Gueudet et al., Blockade of neurokinin(3) receptors antagonizes drug-induced population response and depolarization block of midbrain dopamine neurons in guinea pigs, SYNAPSE, 33(1), 1999, pp. 71-79
Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D-2 function
Authors: Alonso, R Voutsinos, B Fournier, M Labie, C Steinberg, R Souilhac, J Le Fur, G Soubrie, P
Citation: R. Alonso et al., Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D-2 function, NEUROSCIENC, 91(2), 1999, pp. 607-620
SR146131: A new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I: In vitro studies
Authors: Bignon, E Bachy, A Boigegrain, R Brodin, R Cottineau, M Gully, D Herbert, JM Keane, P Labie, C Molimard, JC Olliero, D Oury-Donat, F Petereau, C Prabonnaud, V Rockstroh, MP Schaeffer, P Servant, O Thurneyssen, O Soubrie, P Pascal, M Maffrand, JP Le Fur, G
Citation: E. Bignon et al., SR146131: A new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I: In vitro studies, J PHARM EXP, 289(2), 1999, pp. 742-751
SR146131: A new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II: In vivo pharmacological characterization
Authors: Bignon, E Alonso, R Arnone, M Boigegrain, R Brodin, R Gueudet, C Heaulme, M Keane, P Landi, M Molimard, JC Olliero, D Poncelet, M Seban, E Simiand, J Soubrie, P Pascal, M Maffrand, JP Le Fur, G
Citation: E. Bignon et al., SR146131: A new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II: In vivo pharmacological characterization, J PHARM EXP, 289(2), 1999, pp. 752-761
SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist
Authors: Portier, M Rinaldi-Carmona, M Pecceu, F Combes, T Poinot-Chazel, C Calandra, B Barth, F Le Fur, G Casellas, P
Citation: M. Portier et al., SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist, J PHARM EXP, 288(2), 1999, pp. 582-589
Cloning and characterization of PRAX-1 - A new protein that specifically interacts with the peripheral benzodiazepine receptor
Authors: Galiegue, S Jbilo, O Combes, T Bribes, E Carayon, P Le Fur, G Casellas, P
Citation: S. Galiegue et al., Cloning and characterization of PRAX-1 - A new protein that specifically interacts with the peripheral benzodiazepine receptor, J BIOL CHEM, 274(5), 1999, pp. 2938-2952
Stimulation of peripheral cannabinoid receptor CB2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL60
Authors: Jbilo, O Derocq, JM Segui, M Le Fur, G Casellas, P
Citation: O. Jbilo et al., Stimulation of peripheral cannabinoid receptor CB2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL60, FEBS LETTER, 448(2-3), 1999, pp. 273-277
Contrasting roles of Leu(356) in the human CCK1 receptor for antagonist SR27897 and agonist SR 146131 binding
Authors: Gouldson, P Legoux, P Carillon, C Delpech, B Le Fur, G Ferrara, P Shire, D
Citation: P. Gouldson et al., Contrasting roles of Leu(356) in the human CCK1 receptor for antagonist SR27897 and agonist SR 146131 binding, EUR J PHARM, 383(3), 1999, pp. 339-346
Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor
Authors: Calandra, B Portier, M Kerneis, A Delpech, M Carillon, C Le Fur, G Ferrara, P Shire, D
Citation: B. Calandra et al., Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor, EUR J PHARM, 374(3), 1999, pp. 445-455
In vitro functional evidence of different neurotensin-receptors modulatingthe motor response of human colonic muscle strips
Authors: Croci, T Aureggi, G Guagnini, F Manara, L Gully, D Le Fur, G Maffrand, JP Mukenge, S Ferla, G Ferrara, P Chalon, P Vita, N
Citation: T. Croci et al., In vitro functional evidence of different neurotensin-receptors modulatingthe motor response of human colonic muscle strips, BR J PHARM, 127(8), 1999, pp. 1922-1928
Effect of the neuroprotective compound SR57746A on nerve growth factor synthesis in cultured astrocytes from neonatal rat cortex
Authors: Labie, C Lafon, C Marmouget, C Saubusse, P Fournier, J Keane, PE Le Fur, G Soubrie, P
Citation: C. Labie et al., Effect of the neuroprotective compound SR57746A on nerve growth factor synthesis in cultured astrocytes from neonatal rat cortex, BR J PHARM, 127(1), 1999, pp. 139-144
Peripheral benzodiazepine receptor agonists exhibit potent antiapoptotic activities
Authors: Bono, F Lamarche, I Prabonnaud, V Le Fur, G Herbert, JM
Citation: F. Bono et al., Peripheral benzodiazepine receptor agonists exhibit potent antiapoptotic activities, BIOC BIOP R, 265(2), 1999, pp. 457-461
Risultati: 1-25 | 26-28